Latest news
GLP SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fili - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:25:40 GMTGLP: Q2 2026 delivered strong profit and margin growth, with robust cash flow and higher distributions - TradingViewTradingView · Fri, 07 Aug 2026 13:25:00 GMTSandoz Earns ‘Blue Chip’ Status With Biosimilars Growth And GLP-1 Opportunity - insights.citeline.cominsights.citeline.com · Thu, 06 Aug 2026 10:30:54 GMTGLP-1 Q2 earnings reinforce Lilly's lead over Novo - eMarketereMarketer · Wed, 05 Aug 2026 20:05:40 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTLLY Q2 Earnings Top, GLP-1 Drugs Fuel Growth, Sales Guidance Raised - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 16:07:00 GMTNVO Stock Down Despite Q2 Earnings and Sales Beat on GLP-1 Growth - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 15:00:00 GMTGLP-1’s Drove Eli Lilly’s Record-Breaking Q2, but AI Will Be Its Future - 24/7 Wall St.24/7 Wall St. · Wed, 05 Aug 2026 13:50:30 GMT